The limited in vivo data reported for other new-generation tau tracers showed similar results to our study: [18F]-MK6240, [18F]RO-948, and [18F]-PI6260 showed elevated signals in temporal areas and more broadly throughout the cortex in AD patients compared to NC subjects. The gene discussed is MAPT; the disease is Alzheimer disease.